ContentsUse this page to navigate through the magazine.P3: Editor's NoteP4: Harnessing Digital Technology for Future Clinical TrialsP5: Clario: Unlock Richer Clinical EvidenceP6: Leveraging AI for Precision and Equity: A Novel Approach to Endpoint Data Collection in Clinical TrialsP6: Clinical Trials for EpilepsyP7. ICON: Meet Critical MilestonesP8. Harnessing the Science of Psychedelic Compounds for the Treatment of Brain and Mental Health DisordersP9. How Relevant are DCTs Post-Pandemic?P10. Allucent: Bringing InnovationP11. The Utility of Drug Repurposing in Orphan Disease ResearchP12. Confidently Compliant? Considerations for Industry Players to Meet the New EMA Guideline ExpectationsP13. 4G Clinical: RTSM and Supply OptimizationP14. Clinical Trials for Epilepsy: Challenges and Promises of Wearable DevicesP15. Complexity in Clinical Trials: Overcoming Operational Challenges with RTSM/IRT SolutionsP16. Worldwide Clinical Trials: Tailored SolutionsP17: Clinical Trial Support: What We Can Learn from the Leukemia & Lymphoma SocietyP18: Optimizing Trial Efficiency with Bayesian Dose Escalation DesignsP19: Site Perspectives in Decentralized Clinical TrialsP20: Leading Industry Service Providers P21: Contact UsCover PagePrevious pageEditor's NoteNext page